Venetoclax plus daratumumab induce hematological CR and organ response in an AL amyloidosis patient with t(11;14).

Autor:	Ghilardi G; a Clinic of Hematology, Oncology Institute of Southern Switzerland , Bellinzona , Switzerland., Stussi G; a Clinic of Hematology, Oncology Institute of Southern Switzerland , Bellinzona , Switzerland., Mazzucchelli L; b Service of Clinical Cytopathology, Cantonal Institute of Pathology , Locarno , Switzerland., Röcken C; c Department of Pathology, Christian-Albrechts-University Kiel , Kiel , Germany., Rossi D; a Clinic of Hematology, Oncology Institute of Southern Switzerland , Bellinzona , Switzerland., Gerber B; a Clinic of Hematology, Oncology Institute of Southern Switzerland , Bellinzona , Switzerland.
Jazyk:	angličtina
Zdroj:	Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis [Amyloid] 2019 Sep; Vol. 26 (3), pp. 173-174. Date of Electronic Publication: 2019 Jun 22.
DOI:	10.1080/13506129.2019.1615428
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.